Home › Funds › Goldman Sachs › Goldman Sachs Multi-Strategy Alternatives Fund
Fund family: Goldman Sachs · Filed by Goldman Sachs Trust II (CIK 1557156) · SEC series S000040071
Share classes and tickers: GIMMX (C000124403), GMAMX (C000124400), GMCMX (C000124401), GMMFX (C000198936), GMMPX (C000201711), GSMMX (C000124402)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 2,173 with, 2 against, 2 abstentions (not counted as with management); 7 items carried no recommendation; 6 split votes are in neither count. Shareholder proposals: 1 FOR, 1 AGAINST, 0 abstained, by the filing’s own vote-source field.
The same two figures as Goldman Sachs’s manager page (297,743 ballot items across 86 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | Goldman Sachs | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 95.3% | 2,122 | 94.3% | 240,212 |
| Backed environmental and social shareholder proposals at US companies | n/a | 0 | 0.0% | 2,372 |
Each ballot item this fund voted is set against the votes of the other Goldman Sachs funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted differently from most Goldman Sachs funds on 42 items (4.2% of the 993 items where a comparison was possible).
| Company | Meeting | Item | This fund | Most Goldman Sachs funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| Guardant Health, Inc. | 2026-06-17 | Election of Class II Directors: Manuel Hidalgo Medina | For | WITHHOLD — 16 of 16 Goldman Sachs funds | For | Elected, 75.5% support |
| Madrigal Pharmaceuticals, Inc. | 2026-06-17 | Re-election of Class I directors: Julian Baker | Withhold | FOR — 15 of 15 Goldman Sachs funds | Against | Elected, 88.6% support |
| Praxis Precision Medicines, Inc. | 2026-06-10 | To elect the Class III Directors to serve until the 2029 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: William Young | For | WITHHOLD — 10 of 10 Goldman Sachs funds | For | Passed (calculated), 85.5% support |
| Century Communities, Inc. | 2026-05-06 | To approve, on an advisory basis, our executive compensation. | For | AGAINST — 9 of 9 Goldman Sachs funds | For | Approved, 88.6% support |
| Alkermes plc | 2026-05-20 | To approve the Alkermes plc 2018 Stock Option and Incentive Plan, as amended. | For | AGAINST — 7 of 7 Goldman Sachs funds | For | — |
| Clear Secure, Inc. | 2026-06-10 | Approval of an amendment to our Certificate of Incorporation to clarify the officer exculpation provision. | For | AGAINST — 7 of 7 Goldman Sachs funds | For | Approved, 99.5% support |
| Hut 8 Corp. | 2026-06-11 | To approve, on an advisory basis, the compensation of our named executive officers. | Against | FOR — 7 of 7 Goldman Sachs funds | Against | Approved, 54.8% support |
| United Community Banks, Inc. | 2026-05-13 | To approve, on an advisory basis, the compensation of our named executive officers. | For | AGAINST — 7 of 7 Goldman Sachs funds | For | Approved, 95.9% support |
| Kontoor Brands, Inc. | 2026-04-23 | To elect six directors for a term ending at the 2027 annual meeting of shareholders: Robert K. Shearer | Against | FOR — 7 of 7 Goldman Sachs funds | Against | Passed (calculated), 99.0% support |
| Applied Optoelectronics, Inc. | 2026-06-04 | To approve the 2026 equity incentive plan. | Against | FOR — 7 of 7 Goldman Sachs funds | Against | Passed (calculated), 90.2% support |
| Viridian Therapeutics, Inc. | 2026-06-02 | To elect the two Class II director nominees to serve until the 2029 Annual Meeting of Stockholders, and until their successors are duly elected and qualified: Tomas Kiselak | Withhold | FOR — 7 of 7 Goldman Sachs funds | Against | Elected, 83.3% support |
| CarGurus, Inc. | 2026-06-03 | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers for 2025. | Against | FOR — 7 of 7 Goldman Sachs funds | Against | Approved, 94.3% support |
| Hut 8 Corp. | 2026-06-11 | To approve an amendment to the Amended and Restated Hut 8 Corp. 2023 Omnibus Incentive Plan. | Against | FOR — 6 of 6 Goldman Sachs funds | Against | Approved, 84.8% support |
| Belden Inc. | 2026-05-21 | Election of Directors: David J. Aldrich | Against | FOR — 6 of 6 Goldman Sachs funds | Against | Passed (calculated), 93.8% support |
| MKS Inc. | 2026-05-11 | The approval, on an advisory basis, of a Company proposal to reduce the threshold percentage of shareholders required to call a special meeting of shareholders from 40% to 25%. | Abstain | FOR — 5 of 5 Goldman Sachs funds | Against | Passed (calculated), 98.5% support |
| Travere Therapeutics Inc. | 2026-05-19 | To approve the Company's 2018 Equity Incentive Plan, as amended, to increase the number of shares of common stock authorized for issuance thereunder by 3,000,000 shares. | For | AGAINST — 5 of 5 Goldman Sachs funds | For | Approved, 96.3% support |
| MARA Holdings, Inc. | 2026-06-18 | A non-binding, advisory vote on the compensation of our Named Executive Officers ("Say-on-Pay"). | Against | FOR — 5 of 5 Goldman Sachs funds | Against | Approved, 59.1% support |
| Marqeta, Inc. | 2026-06-10 | To approve, on a non-binding advisory basis, the compensation of our named executive officers. | Against | FOR — 5 of 5 Goldman Sachs funds | Against | Passed (calculated), 78.5% support |
| IonQ, Inc. | 2026-06-16 | To approve, on an advisory basis, the compensation of our named executive officers in 2025. | Against | FOR — 8 of 9 Goldman Sachs funds | Against | Approved, 53.7% support |
| Abercrombie & Fitch Co. | 2026-06-03 | Election of Directors: Kerrii B. Anderson | Against | FOR — 4 of 4 Goldman Sachs funds | Against | Elected, 98.5% support |
| Chesapeake Utilities Corporation | 2026-05-06 | Approve, on an advisory non-binding basis, the compensation of the Company's Named Executive Officers. | For | AGAINST — 4 of 4 Goldman Sachs funds | For | — |
| Assured Guaranty Ltd. | 2026-05-01 | Election of the following nominees as directors of Assured Guaranty Ltd. (the "Company") for a term expiring at the 2027 annual general meeting: Antonio Ursano, Jr. | Against | FOR — 4 of 4 Goldman Sachs funds | Against | Passed (calculated), 91.4% support |
| Voyager Technologies, Inc. | 2026-05-29 | To approve an adjournment of the Annual Meeting, if necessary, to solicit addition proxies if there are not sufficient votes at the time of the Annual Meeting to approve Proposal 3. | Against | FOR — 4 of 4 Goldman Sachs funds | Against | — |
| Voyager Technologies, Inc. | 2026-05-29 | To approve the Redomestication of the Company from Delaware to Texas. | Against | FOR — 4 of 4 Goldman Sachs funds | Against | Approved, 92.3% support |
| TTM Technologies, Inc. | 2026-05-07 | To elect class II Directors: Julie S. England | For | AGAINST — 3 of 3 Goldman Sachs funds | For | Elected, 86.0% support |
| Company | Meeting | Item | This fund | Most Goldman Sachs funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| Impinj, Inc. | 2026-05-28 | To approve, on an advisory basis, the compensation of our named executive officers. | For | AGAINST — 3 of 3 Goldman Sachs funds | For | Approved, 96.0% support |
| The Chefs' Warehouse, Inc. | 2026-05-08 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers as disclosed in the 2026 Proxy Statement. | Against | FOR — 3 of 3 Goldman Sachs funds | Against | Approved, 51.0% support |
| Solaris Energy Infrastructure, Inc. | 2026-05-15 | Approve, on a non-binding advisory basis, the compensation of the Company's named executive officers for the year ended December 31, 2025. | Against | FOR — 5 of 6 Goldman Sachs funds | Against | Passed (calculated), 86.4% support |
| Simmons First National Corporation | 2026-05-13 | To adopt the following non-binding resolution approving the compensation of the named executive officers of the Company: "RESOLVED, that the compensation paid to the Company's named executive officers, as disclosed in the proxy statement pursuant to Item 402 of Regulation S-K, including the Compensa | For | AGAINST — 3 of 3 Goldman Sachs funds | For | Passed (calculated), 89.7% support |
| OneSpaWorld Holdings Limited | 2026-06-03 | Election of Directors: Andrew R. Heyer | Withhold | FOR — 5 of 6 Goldman Sachs funds | Against | Plurality election, 44.2% support |
| Inspire Medical Systems, Inc. | 2026-04-30 | Approval of an adjournment of the Annual Meeting, if necessary, to solicit additional proxies if there are not sufficient votes at the time of the Annual Meeting to approve Proposal No. 5 and/or Proposal No. 6. | For | AGAINST — 3 of 3 Goldman Sachs funds | For | Approved, 94.4% support |
| Inspire Medical Systems, Inc. | 2026-04-30 | Approval of an amendment and restatement of the Inspire Medical Systems, Inc. 2018 Incentive Award Plan. | For | AGAINST — 3 of 3 Goldman Sachs funds | For | Approved, 62.0% support |
| Janux Therapeutics, Inc. | 2026-06-11 | To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement. | Against | FOR — 3 of 3 Goldman Sachs funds | Against | Approved, 90.3% support |
| Aeva Technologies, Inc. | 2026-06-18 | Election of Class II Directors: Hrach Simonian | For | WITHHOLD — 3 of 3 Goldman Sachs funds | For | — |
| MKS Inc. | 2026-05-11 | Shareholder A shareholder proposal to reduce the threshold percentage of shareholders required to call a special meeting of shareholders from 40% to 10%, if properly presented at the meeting. | For | AGAINST — 4 of 5 Goldman Sachs funds | Against | Failed (calculated), 32.6% support |
| Clearwater Analytics Holdings, Inc. | 2026-05-06 | To approve by, advisory (non-binding) vote, the compensation that may be paid or become payable to the named executive officers of the Company in connection with the consummation of the Merger. | For | AGAINST — 4 of 5 Goldman Sachs funds | For | Passed (calculated), 97.7% support |
| First American Financial Corporation | 2026-05-12 | Advisory vote to approve executive compensation. | For | AGAINST — 5 of 8 Goldman Sachs funds | For | — |
| Matador Resources Company | 2026-06-11 | Advisory vote to approve the compensation of the Company's named executive officers | For | AGAINST — 4 of 6 Goldman Sachs funds | For | Approved, 96.1% support |
| UniFirst Corporation | 2025-12-15 | Shareholder To elect two Class II directors, each to serve for a term of three years until the 2029 annual meeting of shareholders and until their respective successors are duly elected and qualified: Arnaud Ajdler | For | WITHHOLD — 2 of 3 Goldman Sachs funds | — | Not elected, 68.5% support |
| UniFirst Corporation | 2025-12-15 | Shareholder To elect two Class II directors, each to serve for a term of three years until the 2029 annual meeting of shareholders and until their respective successors are duly elected and qualified: Michael A. Croatti | For | WITHHOLD — 2 of 3 Goldman Sachs funds | — | Not elected, 71.7% support |
| UniFirst Corporation | 2025-12-15 | To elect two Class II directors, each to serve for a term of three years until the 2029 annual meeting of shareholders and until their respective successors are duly elected and qualified: Joseph M. Nowicki | Withhold | FOR — 2 of 3 Goldman Sachs funds | — | Elected, 21.4% support |
| UniFirst Corporation | 2025-12-15 | To elect two Class II directors, each to serve for a term of three years until the 2029 annual meeting of shareholders and until their respective successors are duly elected and qualified: Steven S. Sintros | Withhold | FOR — 2 of 3 Goldman Sachs funds | — | Elected, 27.2% support |
Download all 42 differences (CSV)
The same votes as “with management” above, by the sector of the company voted on. 95.1% of this fund’s 2,177 such votes could be given a sector; the other 107 (4.9%) are at companies without one and are not in the table.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Finance | 513 | 0 | 0.0% |
| Health Care | 464 | 0 | 0.0% |
| Consumer Discretionary | 271 | 0 | 0.0% |
| Industrials | 210 | 1 | 0.5% |
| Technology | 199 | 1 | 0.5% |
| Energy | 113 | 0 | 0.0% |
| Utilities | 111 | 0 | 0.0% |
| Real Estate | 79 | 0 | 0.0% |
| Basic Materials | 58 | 0 | 0.0% |
| Consumer Staples | 30 | 0 | 0.0% |
| Miscellaneous | 22 | 0 | 0.0% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 1,528 | 0 |
| Say-on-Pay | 265 | 0 |
| Audit-related | 262 | 0 |
| Compensation | 74 | 0 |
| Corporate Governance | 41 | 1 |
| Capital Structure | 18 | 0 |
| Shareholder Rights and Defenses | 14 | 1 |
| Extraordinary Transactions | 10 | 0 |
| Other Social Issues | 1 | 0 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| Bloom Energy Corporation | May 21, 2026 | $2M | 8 | 0 |
| Marqeta, Inc. | June 10, 2026 | $2M | 8 | 0 |
| Magnite, Inc. | June 8, 2026 | $2M | 6 | 0 |
| AAON, Inc. | May 12, 2026 | $2M | 7 | 0 |
| Eastern Bankshares, Inc. | May 18, 2026 | $2M | 8 | 0 |
| The Chefs' Warehouse, Inc. | May 8, 2026 | $2M | 11 | 0 |
| American Healthcare REIT, Inc. | June 24, 2026 | $2M | 11 | 0 |
| Ameris Bancorp | May 21, 2026 | $2M | 12 | 0 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| May 11, 2026 | MKS Inc. | A shareholder proposal to reduce the threshold percentage of shareholders required to call a special meeting of shareholders from 40% to 10%, if properly presented at the meeting. Shareholder proposal | For | Against |
| June 3, 2026 | Power Integrations, Inc. | To consider, if properly presented at the Annual Meeting, a stockholder proposal related to the separation of the office of Chairman of the Board and the office of Chief Executive Officer. Shareholder proposal | Against | For |
Meetings with a proxy contest or competing nominees (1 in 2025-2026), and how the fund voted the items on its ballot.
2,213 ballot items at 266 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, Goldman Sachs Multi-Strategy Alternatives Fund (GIMMX) voted at 266 shareholder meetings of 262 companies, on 2,213 ballot items in all. Where management made a recommendation, the fund followed it on 99.8% of the items and voted against it 2 times. Its most frequent area of disagreement was corporate governance (1 of its votes against management). It voted on 4 shareholder proposals. It voted FOR the board's own proposals more often than Goldman Sachs's funds as a whole (95.3% against 94.3%). It voted differently from most Goldman Sachs funds on 42 items. 1 of its meetings was contested.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Goldman Sachs’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.